ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Humoral Immunity to CMV Remains Intact after Dual Targeting Desensitization in Allosensitized Nonhuman Primates

P. Schroder, B. Ezekian, F. Saccoccio, J. Yoon, M. Dennis, K. Freischlag, J. Kwun, S. Permar, S. Knechtle.

Department of Surgery, Duke University Medical Center, Durham, NC.

Meeting: 2018 American Transplant Congress

Abstract number: D32

Keywords: Alloantibodies, Cytomeglovirus, Primates

Session Information

Session Name: Poster Session D: Immunosuppression Preclinical Studies

Session Type: Poster Session

Date: Tuesday, June 5, 2018

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Desensitization to remove donor specific antibody (DSA) is a way to expand the pool of potential donors for sensitized patients. This study compared the effects of desensitization on humoral alloimmunity to humoral CMV immunity in allosensitized nonhuman primates. Nonhuman primates (Macaca mulatta) were sensitized with two allogeneic skin transplants and treated with carfilzomib (CFZ) and tocilizumab (TCZ) for desensitization. Kidney transplants from the same donor were performed with anti-CD4/CD8 induction; tacrolimus, MMF, and steroid maintenance immunosuppression; and valganciclovir or ganciclovir viral prophylaxis. The DSA was measured by flow cytometry crossmatch, and rhCMV-gB IgG levels were measured by ELISA. Total cell counts in peripheral blood were measured by flow cytometry. There was no significant difference in rhCMV-gB IgG ED50 (6235 ± 2339 vs. 5447 ± 2339; n=6) at times pre- and post-desensitization. There was a significant difference in DSA (MFI 5775 ± 349 vs. 3713 ± 449; n=6; p<0.01) at times pre- and post-desensitization (See Figure 1). No significant differences were found in CD4+ T cell numbers (0.08 ± 0.02 x103/[mu]L vs. 0.07 ± 0.03 x103/[mu]L; n=4), CD20+ B cell numbers (0.15 ± 0.01 x103/[mu]L vs. 0.24 ± 0.11 x103/[mu]L; n=4), or rhCMV-gB IgG ED50 (9284 ± 5984 vs. 6792 ± 2377; n=4) at post-op week 0 vs. post-op week 2 after kidney transplant. Significant differences were found in CD8+ T cell numbers (0.42 ± 0.09 x103/[mu]L vs. 0 ± 0 x103/[mu]L; n=4; p<0.05) at post-op week 0 vs. post-op week 2 after kidney transplant. CMV reactivation with viremia was observed in 4 subjects, and 2 subjects had CMV disease after kidney transplant. Dual targeting desensitization with CFZ and TCZ significantly decreased DSA while leaving CMV specific antibodies unaffected. However, a significant number of recipients developed CMV reactivation after kidney transplantation. These results demonstrate some selectivity in dual targeting desensitization, but demonstrate the importance of preserving cellular immunity for controlling CMV in the sensitized nonhuman primate.

CITATION INFORMATION: Schroder P., Ezekian B., Saccoccio F., Yoon J., Dennis M., Freischlag K., Kwun J., Permar S., Knechtle S. Humoral Immunity to CMV Remains Intact after Dual Targeting Desensitization in Allosensitized Nonhuman Primates Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Schroder P, Ezekian B, Saccoccio F, Yoon J, Dennis M, Freischlag K, Kwun J, Permar S, Knechtle S. Humoral Immunity to CMV Remains Intact after Dual Targeting Desensitization in Allosensitized Nonhuman Primates [abstract]. https://atcmeetingabstracts.com/abstract/humoral-immunity-to-cmv-remains-intact-after-dual-targeting-desensitization-in-allosensitized-nonhuman-primates/. Accessed May 8, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences